Results 261 to 270 of about 157,049 (314)
Thermally Activated Delayed Fluorescence and Beyond. Photophysics and Material Design Strategies.
Photophysical properties of TADF molecules are determined by characteristic parameters that are discussed in detail(. Moreover, using femtosecond time‐resolved spectroscopy, quantum mechanical considerations, and state‐of‐art calculations, deeper understanding allows us to design breakthrough Cu(I) and organic TADF‐ OLED materials. For the latter ones,
Hartmut Yersin, Uwe Monkowius
wiley +1 more source
Nanotechnology-based strategies for vaccine development: accelerating innovation and delivery. [PDF]
Cheng M+6 more
europepmc +1 more source
Immunological enhancement of micro-nanoparticle formulated with risedronate and zinc as vaccine adjuvant in aged mice. [PDF]
Liu Y+14 more
europepmc +1 more source
Self-assembled Ac-FFA-NH<sub>2</sub> based hydrogels with strong immunostimulating activity for vaccine delivery. [PDF]
Serdar NG+6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
International Reviews of Immunology, 1990
In summary, HIV vaccine studies described have generally not been designed to measure the effect of the adjuvant or to make comparisons between adjuvants. In only one study was a head-to-head comparison made between HIV antigen alone and antigen formulated with different adjuvants. We hope that future experiments with HIV/SIV vaccine candidates will be
R, Edelman, C O, Tacket
openaire +2 more sources
In summary, HIV vaccine studies described have generally not been designed to measure the effect of the adjuvant or to make comparisons between adjuvants. In only one study was a head-to-head comparison made between HIV antigen alone and antigen formulated with different adjuvants. We hope that future experiments with HIV/SIV vaccine candidates will be
R, Edelman, C O, Tacket
openaire +2 more sources
Adjuvant activity of incomplete Freund's adjuvant
Advanced Drug Delivery Reviews, 1998The water-in-oil emulsion adjuvants developed by Jules Freund and coworkers have been, and continue to be, used in research and veterinary vaccines. Incomplete Freund's Adjuvant (IFA) has also been widely tested in humans where it was shown to augment antibody responses greater than other adjuvants, such as alum, and to be well tolerated.
Jay R Savary+3 more
openaire +3 more sources